Received Nov 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y010466 | — |
No additional AEs were reported; The healthcare worker is reporting that a patient received improperly stored vaccine. No additional AEs were reported, no further information provided. Names of vaccines involved (including lot/exp) GARDASIL 9 y010466 10/29/2026 Temperature: 31.3; This spontaneous report was received from an other health professional and refers to a(n) patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 28-May-2025, the patient was vaccinated with a dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (1 dose) (lot #Y010466 with expiration date reported as and upon internal validation confirmed to be 29-Oct-2026) (dose, route of administration and vaccination site were not reported) administered for prophylaxis. The patient received an improperly stored vaccine (temperature: 31.3F; time frame: 15 minutes; previous temperature excursion: no) (product storage error). No additional adverse events (AEs) were reported (no adverse event). No further information was provided.